William Clarke Selected Research

William Clarke Research Topics

Disease

10	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2014 - 01/2006
7	Neoplasms (Cancer) 01/2020 - 12/2009
7	HIV Infections (HIV Infection) 01/2020 - 01/2014
7	Hypoglycemia (Reactive Hypoglycemia) 11/2014 - 08/2003
4	COVID-19 01/2022 - 09/2020
4	Infections 01/2022 - 12/2011
2	Chronic Pain 01/2020 - 04/2009
2	Obesity 01/2020 - 01/2016
2	Multiple Myeloma 01/2020 - 02/2004
2	Heart Failure 04/2011 - 08/2009
2	Pain (Aches) 04/2009 - 02/2004
2	Aneurysm (Aneurysms) 03/2009 - 04/2008
2	Intracranial Aneurysm (Cerebral Aneurysm) 03/2009 - 04/2008
2	Stroke (Strokes) 04/2008 - 01/2004
2	Hyperglycemia 01/2008 - 11/2006
2	Type 2 Diabetes Mellitus (MODY) 06/2007 - 07/2002
1	Kidney Diseases (Kidney Disease) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Cardiotoxicity 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Opiate Overdose 01/2020
1	Lymphoma (Lymphomas) 01/2020
1	Leukemia 01/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2020
1	Obstructive Sleep Apnea 01/2020
1	Rheumatoid Arthritis 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Substance-Related Disorders (Drug Abuse) 10/2018
1	Critical Illness (Critically Ill) 04/2017
1	Insulin Resistance 01/2016
1	Body Weight (Weight, Body) 06/2015
1	Depressive Disorder (Melancholia) 06/2015
1	Viremia 12/2011
1	Neuralgia (Stump Neuralgia) 04/2009
1	Hypersensitivity (Allergy) 04/2009
1	Hyperalgesia 04/2009
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 03/2009
1	Neurologic Manifestations (Neurological Manifestations) 03/2009
1	Brain Ischemia (Cerebral Ischemia) 03/2009

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 01/2022 - 12/2008
8	Blood Glucose (Blood Sugar)IBA 04/2017 - 12/2004
6	Glucose (Dextrose)FDA LinkGeneric 04/2017 - 07/2002
5	Insulin (Novolin)FDA Link 12/2009 - 08/2003
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2011 - 08/2003
3	CreatinineIBA 01/2022 - 08/2009
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2009
3	Immunoglobulin G (IgG)IBA 01/2021 - 09/2020
2	AntibodiesIBA 01/2021 - 09/2020
2	CLR1404IBA 06/2014 - 01/2014
2	pro-brain natriuretic peptide (1-76)IBA 04/2011 - 01/2006
2	Nitrous Oxide (Laughing Gas)IBA 03/2009 - 04/2008
1	Protons (Proton)IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Phosphocreatine (Neoton)IBA 01/2021
1	Phosphorus (Red Phosphorus)IBA 01/2021
1	AnthracyclinesIBA 01/2021
1	Morphine (MS Contin)FDA LinkGeneric 01/2020
1	Biological ProductsIBA 01/2020
1	Busulfan (Busulfex)FDA Link 01/2020
1	LeptinIBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	RacivirIBA 01/2017
1	Triglycerides (Triacylglycerol)IBA 01/2016
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 06/2015
1	Antidepressive Agents (Antidepressants)IBA 06/2015
1	Escitalopram FDA Link 06/2015
1	EnzymesIBA 01/2015
1	AntigensIBA 01/2015
1	RNA (Ribonucleic Acid)IBA 12/2014
1	Phospholipid EthersIBA 06/2014
1	Biological FactorsIBA 01/2014
1	Radioisotopes (Radionuclides)IBA 01/2014
1	taxaneIBA 02/2013
1	Docetaxel (Taxotere)FDA Link 02/2013
1	Neutralizing AntibodiesIBA 12/2011
1	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2011
1	Fluorouracil (Carac)FDA LinkGeneric 12/2009
1	Cystatin CIBA 08/2009
1	LigandsIBA 04/2009
1	Estrogen ReceptorsIBA 04/2009
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 04/2009
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2009
1	PPAR alphaIBA 04/2009
1	PPAR gammaIBA 04/2009
1	SalicylatesIBA 12/2008

Therapy/Procedure

6	Therapeutics 01/2020 - 05/2007
5	Drug Therapy (Chemotherapy) 01/2021 - 12/2009
2	Glycemic Control 11/2014 - 08/2003
2	Artificial Pancreas 11/2010 - 01/2009
1	Pain Management 01/2020
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2020
1	Transplantation 01/2020
1	Art Therapy 10/2018
1	Transjugular Intrahepatic Portasystemic Shunt 06/2015
1	Withholding Treatment 12/2011
1	Aftercare (After-Treatment) 12/2011
1	Highly Active Antiretroviral Therapy (HAART) 12/2011
1	Length of Stay 04/2011